Nektar Therapeutics (NKTR) stock
NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
$34.42−1.49 (-4.15%)
Close on Nov 18, 2026Market cap $1.18BP/E –Yield –
Nektar Therapeutics market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Nektar Therapeutics's market cap was $783.36M on Nov 11, 2026, against $1.28B a year earlier. Over the last 5 years it ranged from $89.16M to $2.49B, with a median of $371.97M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $783.36M | -5.7% |
| 2025 | Dec 31, 2025 | $830.91M | +384.4% |
| 2024 | Dec 31, 2024 | $171.54M | +60.6% |
| 2023 | Dec 29, 2023 | $106.83M | -74.8% |
| 2022 | Dec 30, 2022 | $424.75M | -83.0% |
| 2021 | Dec 31, 2021 | $2.49B | -18.2% |
| 2020 | Dec 31, 2020 | $3.05B | -19.6% |
| 2019 | Dec 31, 2019 | $3.79B | -33.3% |
| 2018 | Dec 31, 2018 | $5.69B | -39.3% |
| 2017 | Dec 29, 2017 | $9.37B | +454.4% |
| 2016 | Dec 30, 2016 | $1.69B | -24.7% |
| 2015 | Dec 31, 2015 | $2.24B | +12.9% |
| 2014 | Dec 31, 2014 | $1.99B | +51.0% |
| 2013 | Dec 31, 2013 | $1.32B | +54.4% |
| 2012 | Dec 31, 2012 | $852.69M | +33.1% |
| 2011 | Dec 30, 2011 | $640.79M | – |
See a number that looks wrong?